Primary radical therapy selection in high-risk non-metastatic prostate cancer.

Gnanapragasam, V J; Payne, H; Syndikus, I; Kynaston, H; Johnstone, T

Gnanapragasam, V J; Payne, H; Syndikus, I; Kynaston, H; Johnstone, T.

Afiliação

Gnanapragasam VJ; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, UK; Translational Prostate Cancer Group, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, UK. Electronic address: vjg29@cam.ac.uk.
Payne H; Department of Oncology, University College London, London, UK.
Syndikus I; Clatterbridge Cancer Centre, Wirral, UK.
Kynaston H; Department of Urology, University Hospital of Wales, Cardiff, UK.
Johnstone T; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, UK.

Clin Oncol (R Coll Radiol) ; 27(3): 136-44, 2015 Mar.

Article em En | MEDLINE | ID: mdl-25441052

Assuntos

Neoplasias da Próstata/radioterapia; Progressão da Doença; Humanos; Masculino; Radioterapia Adjuvante; Resultado do Tratamento

Palavras-chave

Decision algorithm; high risk; prostate cancer; radical prostatectomy; radical radiotherapy; rational therapy selection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Clin Oncol (R Coll Radiol) Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google